GLP1R and breast carcinoma: On the other hand, antidiabetic drugs such as pioglitazone, GLP-1 receptor antagonists, and insulin analogues are reported to be associated with bladder, medullary thyroid, and breast cancers, respectively, although there are some conflicting results43.